Selected research
Industry Growth & Trends
Global Exosome Manufacturing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Exosome Manufacturing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Exosome Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Exosome Manufacturing Service market include Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, SBI, Creative-Biolabs, Esco Aster and EXO Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Exosome Manufacturing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Exosome Manufacturing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Exosome Manufacturing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Exosome Manufacturing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Exosome Manufacturing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Exosome Manufacturing Service Market by Company
Guidon (Beijing) Pharmaceutical Technology
Cytoniche
EverZom
Lonza
RoosterBio
SBI
Creative-Biolabs
Esco Aster
EXO Biologics
Eppendorf
Aethlon Medical
Exosome Manufacturing Service Segment by Type
Human Embryonic Kidney Cell-Derived Exosomes
Bone Marrow Stem Cell-Derived Exosomes
Immature Dendritic Cell-Derived Exosomes
Milk-Derived Exosomes
Red Blood Cell-Derived Exosomes
Others
Exosome Manufacturing Service Segment by Application
Laboratory
Pharmaceutical Companies
Others
Exosome Manufacturing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Exosome Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Exosome Manufacturing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Human Embryonic Kidney Cell-Derived Exosomes
- Bone Marrow Stem Cell-Derived Exosomes
- Immature Dendritic Cell-Derived Exosomes
- Milk-Derived Exosomes
- Red Blood Cell-Derived Exosomes
- Others
Applications
- Laboratory
- Pharmaceutical Companies
- Others
Companies covered
- Guidon (Beijing) Pharmaceutical Technology
- Cytoniche
- EverZom
- Lonza
- RoosterBio
- SBI
- Creative-Biolabs
- Esco Aster
- EXO Biologics
- Eppendorf
- Aethlon Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Exosome Manufacturing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Exosome Manufacturing Service Market Size by Region (2021-2032)
- 1.4.1 Global Exosome Manufacturing Service Market Size by Region (2021-2026)
- 1.4.2 Global Exosome Manufacturing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Exosome Manufacturing Service Market Size (2021-2032)
- 1.5.1 North America Exosome Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Exosome Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Exosome Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Exosome Manufacturing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Exosome Manufacturing Service Market Size Growth Rate (2021-2032)
2 Exosome Manufacturing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Human Embryonic Kidney Cell-Derived Exosomes
- 2.1.2 Bone Marrow Stem Cell-Derived Exosomes
- 2.1.3 Immature Dendritic Cell-Derived Exosomes
- 2.1.4 Milk-Derived Exosomes
- 2.1.5 Red Blood Cell-Derived Exosomes
- 2.1.6 Others
- 2.2 Global Exosome Manufacturing Service Market Size by Type
- 2.2.1 Global Exosome Manufacturing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Exosome Manufacturing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Exosome Manufacturing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Exosome Manufacturing Service Market Size by Regions
- 2.3.1 North America Exosome Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Exosome Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Exosome Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Exosome Manufacturing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Exosome Manufacturing Service Market Size Breakdown by Type (2021-2026)
3 Exosome Manufacturing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Laboratory
- 3.1.2 Pharmaceutical Companies
- 3.1.3 Others
- 3.2 Global Exosome Manufacturing Service Market Size by Application
- 3.2.1 Global Exosome Manufacturing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Exosome Manufacturing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Exosome Manufacturing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Exosome Manufacturing Service Market Size by Regions
- 3.3.1 North America Exosome Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Exosome Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Exosome Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Exosome Manufacturing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Exosome Manufacturing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Exosome Manufacturing Service Industry Trends
- 4.2 Exosome Manufacturing Service Industry Drivers
- 4.3 Exosome Manufacturing Service Industry Opportunities and Challenges
- 4.4 Exosome Manufacturing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Exosome Manufacturing Service Revenue (2021-2026)
- 5.2 Global Exosome Manufacturing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Exosome Manufacturing Service Key Company Headquarters & Area Served
- 5.4 Global Exosome Manufacturing Service Company, Product Type & Application
- 5.5 Global Exosome Manufacturing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Exosome Manufacturing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Exosome Manufacturing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Exosome Manufacturing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Guidon (Beijing) Pharmaceutical Technology
- 6.1.1 Guidon (Beijing) Pharmaceutical Technology Company Information
- 6.1.2 Guidon (Beijing) Pharmaceutical Technology Business Overview
- 6.1.3 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Portfolio
- 6.1.5 Guidon (Beijing) Pharmaceutical Technology Recent Developments
- 6.2 Cytoniche
- 6.2.1 Cytoniche Company Information
- 6.2.2 Cytoniche Business Overview
- 6.2.3 Cytoniche Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Cytoniche Exosome Manufacturing Service Product Portfolio
- 6.2.5 Cytoniche Recent Developments
- 6.3 EverZom
- 6.3.1 EverZom Company Information
- 6.3.2 EverZom Business Overview
- 6.3.3 EverZom Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 EverZom Exosome Manufacturing Service Product Portfolio
- 6.3.5 EverZom Recent Developments
- 6.4 Lonza
- 6.4.1 Lonza Company Information
- 6.4.2 Lonza Business Overview
- 6.4.3 Lonza Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Lonza Exosome Manufacturing Service Product Portfolio
- 6.4.5 Lonza Recent Developments
- 6.5 RoosterBio
- 6.5.1 RoosterBio Company Information
- 6.5.2 RoosterBio Business Overview
- 6.5.3 RoosterBio Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 RoosterBio Exosome Manufacturing Service Product Portfolio
- 6.5.5 RoosterBio Recent Developments
- 6.6 SBI
- 6.6.1 SBI Company Information
- 6.6.2 SBI Business Overview
- 6.6.3 SBI Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 SBI Exosome Manufacturing Service Product Portfolio
- 6.6.5 SBI Recent Developments
- 6.7 Creative-Biolabs
- 6.7.1 Creative-Biolabs Company Information
- 6.7.2 Creative-Biolabs Business Overview
- 6.7.3 Creative-Biolabs Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Creative-Biolabs Exosome Manufacturing Service Product Portfolio
- 6.7.5 Creative-Biolabs Recent Developments
- 6.8 Esco Aster
- 6.8.1 Esco Aster Company Information
- 6.8.2 Esco Aster Business Overview
- 6.8.3 Esco Aster Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Esco Aster Exosome Manufacturing Service Product Portfolio
- 6.8.5 Esco Aster Recent Developments
- 6.9 EXO Biologics
- 6.9.1 EXO Biologics Company Information
- 6.9.2 EXO Biologics Business Overview
- 6.9.3 EXO Biologics Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 EXO Biologics Exosome Manufacturing Service Product Portfolio
- 6.9.5 EXO Biologics Recent Developments
- 6.10 Eppendorf
- 6.10.1 Eppendorf Company Information
- 6.10.2 Eppendorf Business Overview
- 6.10.3 Eppendorf Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Eppendorf Exosome Manufacturing Service Product Portfolio
- 6.10.5 Eppendorf Recent Developments
- 6.11 Aethlon Medical
- 6.11.1 Aethlon Medical Company Information
- 6.11.2 Aethlon Medical Business Overview
- 6.11.3 Aethlon Medical Exosome Manufacturing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Aethlon Medical Exosome Manufacturing Service Product Portfolio
- 6.11.5 Aethlon Medical Recent Developments
7 North America
- 7.1 North America Exosome Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Exosome Manufacturing Service Market Size by Country (2021-2026)
- 7.3 North America Exosome Manufacturing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Exosome Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Exosome Manufacturing Service Market Size by Country (2021-2026)
- 8.3 Europe Exosome Manufacturing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Exosome Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Exosome Manufacturing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Exosome Manufacturing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Exosome Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Exosome Manufacturing Service Market Size by Country (2021-2026)
- 10.3 South America Exosome Manufacturing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Exosome Manufacturing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Exosome Manufacturing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Exosome Manufacturing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst